In a report released today, Cecilia Furlong from Morgan Stanley maintained a Buy rating on Abbott Labs (ABT – Research Report), with a price target of $132.00. The company's shares closed last Wednesday at $108.23. According to TipRanks.com, Furlong is a 4-star analyst with an average return of 19.0% and a 46.4% success rate. Furlong covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Bausch + Lomb Corporation, and Zimmer Biomet Holdings. Abbott Labs has an analyst consensus of Strong Buy, with a price target consensus of $123.45, which is a 15.4% upside from current levels. In a report issued on July 12, J.P.
https://www.tipranks.com/news/blurbs/morgan-stanley-maintains-their-buy-rating-on-abbott-labs-abt?utm_source=advfn.com&utm_medium=referral
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
Von Sep 2022 bis Okt 2022 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
Von Okt 2021 bis Okt 2022 Click Here for more Abbott Laboratories Charts.